Valuation: Carvolix

Market Cap 221M 194M 179M 167M 314M 20.87B 320M 2.15B 832M 10.31B 831M 813M 35.76B P/E 2025 *
-7.32x
P/E 2026 * -7.07x
Enterprise Value 249M 218M 201M 188M 353M 23.49B 361M 2.42B 936M 11.61B 935M 915M 40.26B EV / Sales 2025
-
EV / Sales 2026 * 175x
Free-Float
21.57%
Yield 2025 *
-
Yield 2026 * -
1 week-9.86%
Current month-2.14%
1 month+3.56%
3 months-0.31%
6 months+81.82%
Current year+102.53%
1 week 3.17
Extreme 3.17
3.71
1 month 2.97
Extreme 2.97
4.19
3 years 0.96
Extreme 0.962
4.51
5 years 0.96
Extreme 0.962
6.84
Change 5-day change 1-year change 3-year change Capi.($)
+1.25%-9.86%+154.98%+166.67% 219M
-0.24%+0.14%+24.86%-3.84% 12.48B
+2.84%+4.96%+61.12%+32.89% 5.95B
-1.15%+1.88%+6.38%+8.16% 5.61B
+0.14%+0.14% - - 3.99B
-3.75%-5.41%-37.85%+8.18% 3.91B
-1.95%+3.48%-28.15%-26.32% 3.83B
-0.97%-1.45%+39.32%+256.81% 1.81B
+2.52%+13.37%-9.77%-62.82% 1.74B
0.00%+0.37%+58.74%-6.01% 1.54B
Average -0.25%+0.44%+29.96%+41.52% 4.54B
Weighted average by Cap. -0.24%+0.33%+17.03%+13.65%

Financials

2025 2026 *
Net sales - 1.6M 1.4M 1.29M 1.21M 2.27M 151M 2.31M 15.52M 6.01M 74.5M 6M 5.87M 258M
Net income -22.08M -19.36M -17.85M -16.71M -31.33M -2.08B -31.98M -215M -83.01M -1.03B -82.93M -81.12M -3.57B -33.03M -28.97M -26.7M -25M -46.87M -3.12B -47.84M -321M -124M -1.54B -124M -121M -5.34B
Net Debt 27.81M 24.38M 22.47M 21.04M 39.45M 2.62B 40.27M 270M 105M 1.3B 104M 102M 4.5B 58.74M 51.5M 47.47M 44.44M 83.34M 5.54B 85.07M 571M 221M 2.74B 221M 216M 9.5B
Logo Carvolix
Carvolix (formerly Affluent Medical) specializes in the development of AI-based mini-robots and biomimetic implants designed to autonomously replace heart valves and treat strokes.
Employees
-
Date Price Change
26-06-26 3.240 +1.25%
26-06-25 €3.200 -2.14%
26-06-24 €3.270 -6.30%
26-06-23 €3.490 -2.51%
26-06-22 €3.580 -0.56%
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
3.240EUR
Average target price
5.033EUR
Spread / Average Target
+55.35%

Annual profits - Rate of surprise